Race of the Clock: Reducing Delay to Curative Breast Cancer Surgery

Restricted access

Analysis of Moffitt Cancer Center data on time from breast biopsy to first definitive surgery showed an average of 6.9 weeks, which concerned the breast program faculty members. Delays in curative surgery may impact mortality, quality of life, and time to adjuvant therapy. The purpose of this study was to analyze steps from breast biopsy to definitive breast cancer surgery and to develop proposals and strategies for improvement. Data were collected from various sources, including the tumor registry, patient appointment system, tumor board lists, and the NCCN Oncology Outcomes Database for Breast Cancer. Three phases of the surgical process were identified with regard to lead time: biopsy to first consult (BX-FC); first consult to tumor board (FC-TB); and tumor board to surgery (TB-SU). Other factors, including operating room capacity and schedules, were also evaluated. The greatest percentage of total lead time occurred in the TB-SU phase (52% vs 35% in BX-FC, and 13% in FC-TB phases). The longest average lead time, 3.6 weeks, was also in the TB-SU phase. The TB-SU time was greatest when surgery was scheduled after tumor board and if surgery required breast reconstruction. Limitation of physician capacity was a major factor in treatment delay. The Opportunity for Improvement project enabled institutional analysis of the need for quality improvement in time for curative surgery for breast cancer. A significant factor that created time delay was physician capacity. As a result, additional faculty and staff have been recruited. A new expanded facility is currently in progress that will provide more physical space and services.

Correspondence: Loretta Loftus, MD, MBA, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612.E-mail: loretta.loftus@moffitt.org
  • 1.

    American College of Surgeons Commission on Cancer. National Cancer Database Survival Statistics. Available at: http://www.facs.org/cancer/ncdb/survival.html. Accessed December 16, 2013.

    • Search Google Scholar
    • Export Citation
  • 2.

    Theriault RL, Carlson RW, Allred C. NCCN Clinical Practice Guidelines in Oncology for Breast Cancer. Version 3.2013. Available at NCCN.org. Accessed December 13, 2013.

    • Search Google Scholar
    • Export Citation
  • 3.

    Shin DW, Cho J, Kim SY. Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer. Ann Surg Oncol 2013;20:24682476.

    • Search Google Scholar
    • Export Citation
  • 4.

    Drageset S, Lindstrom TC, Giske T, Underlid K. Being in suspense: women’s experiences awaiting breast cancer surgery. J Adv Nurs 2011;67:19411951.

    • Search Google Scholar
    • Export Citation
  • 5.

    Kontos M, Lewis RS, Luchtenborg M. Does immediate breast reconstruction using free flaps lead to delay in the administration of adjuvant chemotherapy for breast cancer? Eur J Surg Oncol 2010;36:745749.

    • Search Google Scholar
    • Export Citation
  • 6.

    Goktas SB, Gulluoglu BM, Selimen D. Immediate or delayed breast reconstruction after radical mastectomy in breast cancer patients: does it make a difference in the quality of life? Turkiye Klinik J Med Sci 2011;31:664673.

    • Search Google Scholar
    • Export Citation
  • 7.

    Mosunjac M, Park J, Strauss A. Time to treatment for patients receiving BCS in a public and a private university hospital in Atlanta. Breast J 2012;18:163167.

    • Search Google Scholar
    • Export Citation
  • 8.

    Blecicher RJ, Ruth K, Sigurdson ER. Preoperative delays in the US Medicare population with breast cancer. J Clin Oncol 2012;30:44854449.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 108 83 3
PDF Downloads 22 21 0
EPUB Downloads 0 0 0